Population
Patients with polyarteritis nodosa
Design
Other
Authors
Loading...
HCV prevalence assessment in PAN informs possible links; leaves open whether screening should enter routine practice.
This letter aimed to assess the prevalence of HCV markers in patients with polyarteritis nodosa.
Cacoub et al. (1992) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: